Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allogene, Amgen, Astrazeneca, Aulos, Aummune, Indaptus, Kineta, Nektar, Nimbus, Paratek, Radella.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascelia, Ascletis, Impact, Neurocrine, Springworks, Werewolf, Xilio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lunit.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Lexicon, Minghui, Qurebio, Tango, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunovia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beam, Ichnos, Intra-Cellular, Nouscom, Vaccinex, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atossa, Cinfina, Neurocrine, Novo Nordisk, OSE, Teva, Viking.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott Labs, Penuma, Penumbra, Shockwave.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Bioarctic, Clover Biopharmaceuticals, Feliqs, Gemvax & Kael, Henlius, Innovent, Jenscare, Recce, Remegen, Zai.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biofrontera, Bristol Myers, Essa, Novo Nordisk, Supernus, UCB, Vaccinex.